India, May 29 -- Labcorp Holdings Inc. (LH), a laboratory services, announced on Friday its collaboration with the Alliance for Clinical Trials in Oncology to further a national, multicentre clinical trial for patients who are newly diagnosed with colorectal cancer or CRC.
Amongst all colorectal cancer cases, approximately 10% are caused as a result of inherited genetic variants.
The trial will evaluate methods to increase germline genetic testing and multigene panel testing across at-risk family members of newly diagnosed CRC.
The study will assess if proactive outreach by healthcare providers will improve participation of first-degree relatives for cascade genetic testing instead of relying on patients to communicate genetic risk to th...